BRCA1 Directs a Selective p53-Dependent Transcriptional Response towards Growth Arrest and DNA Repair Targets

REFERENCES

• Abbott, D. W., M. E. Thompson, C. Robinson-Benion, G. Tomlinson, R. A. Jensen, and J. T. Holt. 1999. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J. Biol. Chem. 274: 18808–18812.
   PubMed Web of Science ®Google Scholar
• Arizti, P., L. Fang, I. Park, Y. Yin, E. Solomon, T. Ouchi, S. A. Aaronson, and S. W. Lee. 2000. Tumor suppressor p53 is required to modulate BRCA1 expression. Mol. Cell. Biol. 20: 7450–7459.
   PubMedGoogle Scholar
• Attardi, L. D., E. E. Reczek, C. Cosmas, E. G. Demicco, M. E. McCurrach, S. W. Lowe, and T. Jacks. 2000. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14: 704–718.
   PubMed Web of Science ®Google Scholar
• Bates, S., S. Rowan, and K. H. Vousden. 1996. Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene 13: 1103–1109.
   PubMed Web of Science ®Google Scholar
• Chen, J., D. P. Silver, D. Walpita, S. B. Cantor, A. F. Gazdar, G. Tomlinson, F. J. Couch, B. L. Weber, T. Ashley, D. M. Livingston, and R. Scully. 1998. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2: 317–328.
   PubMed Web of Science ®Google Scholar
• Chiba, N., and J. D. Parvin. 2001. Redistribution of BRCA1 among four different protein complexes following replication blockage. J. Biol. Chem. 276: 38549–38554.
   PubMedGoogle Scholar
• Couch, F. J., M. L. DeShano, M. A. Blackwood, K. Calzone, J. Stopfer, L. Campeau, A. Ganguly, T. Rebbeck, and B. L. Weber. 1997. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 336: 1409–1415.
   PubMed Web of Science ®Google Scholar
• Cressman, V. L., D. C. Backlund, E. M. Hicks, L. C. Gowen, V. Godfrey, and B. H. Koller. 1999. Mammary tumor formation in p53- and BRCA1-deficient mice. Cell Growth Differ. 10: 1–10.
   PubMedGoogle Scholar
• Crook, T., L. A. Brooks, S. Crossland, P. Osin, K. T. Barker, J. Waller, E. Philp, P. D. Smith, I. Yulug, J. Peto, G. Parker, M. J. Allday, M. R. Crompton, and B. A. Gusterson. 1998. p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene 17: 1681–1689.
   PubMed Web of Science ®Google Scholar
• Deng, C. X., and F. Scott. 2000. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene 19: 1059–1064.
   PubMedGoogle Scholar
• El-Deiry, W. S. 1998. p21/p53, cellular growth control and genomic integrity. Curr. Top. Microbiol. Immunol. 227: 121–137.
   PubMedGoogle Scholar
• El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
   PubMed Web of Science ®Google Scholar
• Hakem, R., J. L. de la Pompa, C. Sirard, R. Mo, M. Woo, A. Hakem, A. Wakeham, J. Potter, A. Reitmair, F. Billia, E. Firpo, C. C. Hui, J. Roberts, J. Rossant, and T. W. Mak. 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009–1023.
   PubMed Web of Science ®Google Scholar
• Harkin, D. P., J. M. Bean, D. Miklos, Y. H. Song, V. B. Truong, C. Englert, F. C. Christians, L. W. Ellisen, S. Maheswaran, J. D. Oliner, and D. A. Haber. 1999. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97: 575–586.
   PubMed Web of Science ®Google Scholar
• He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95: 2509–2514.
   PubMed Web of Science ®Google Scholar
• Hollander, M. C., M. S. Sheikh, D. V. Bulavin, K. Lundgren, L. Augeri-Henmueller, R. Shehee, T. A. Molinaro, K. E. Kim, E. Tolosa, J. D. Ashwell, M. P. Rosenberg, Q. Zhan, P. M. Fernandez-Salguero, W. F. Morgan, C. X. Deng, and A. J. Fornace, Jr. 1999. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23: 176–184.
   PubMed Web of Science ®Google Scholar
• Irminger-Finger, I., W.-C. Leung, J. Li, M. Dubois-Dauphin, J. Harb, A. Feki, C. E. Jefford, J. V. Soriano, M. Jaconi, R. Montesano, and K.-H. Krause. 2001. Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol. Cell 8: 1255–1266.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587–597.
   PubMed Web of Science ®Google Scholar
• Lehman, T. A., B. G. Haffty, C. J. Carbone, L. R. Bishop, A. A. Gumbs, S. Krishnan, P. G. Shields, R. Modali, and B. C. Turner. 2000. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res. 60: 1062–1069.
   PubMed Web of Science ®Google Scholar
• Lin, Y., W. Ma, and S. Benchimol. 2000. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet. 26: 122–127.
   PubMed Web of Science ®Google Scholar
• Lockhart, D. J., H. Dong, M. C. Byrne, M. T. Follettie, M. V. Gallo, M. S. Chee, M. Mittmann, C. Wang, M. Kobayashi, H. Horton, and E. L. Brown. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14: 1675–1680.
   PubMed Web of Science ®Google Scholar
• MacLachlan, T. K., B. C. Dash, D. T. Dicker, and W. S. El-Deiry. 2000. Repression of BRCA1 through a feedback loop involving p53. J. Biol. Chem. 275: 31869–31875.
   PubMedGoogle Scholar
• MacLachlan, T. K., K. Somasundaram, M. Sgagias, Y. Shifman, R. J. Muschel, K. H. Cowan, and W. S. El-Deiry. 2000. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 275: 2777–2785.
   PubMedGoogle Scholar
• Mak, T. W., A. Hakem, J. P. McPherson, A. Shehabeldin, E. Zablocki, E. Migon, G. S. Duncan, D. Bouchard, A. Wakeham, A. Cheung, J. Karaskova, I. Sarosi, J. Squire, J. Marth, and R. Hakem. 2000. Brca1 required for T cell lineage development but not TCR loci rearrangement. Nat. Immunol. 1: 77–82.
   PubMedGoogle Scholar
• Maltzman, W., and L. Czyzyk. 1984. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4: 1689–1694.
   PubMed Web of Science ®Google Scholar
• Nakano, K., E. Balint, M. Ashcroft, and K. H. Vousden. 2000. A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene 19: 4283–4289.
   PubMed Web of Science ®Google Scholar
• Nichols, K. E., D. Malkin, J. E. Garber, J. F. Fraumeni, Jr., and F. P. Li. 2001. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol. Biomarkers Prev. 10: 83–87.
   PubMed Web of Science ®Google Scholar
• Oda, K., H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, H. Nishimori, K. Tamai, T. Tokino, Y. Nakamura, and Y. Taya. 2000. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849–862.
   PubMed Web of Science ®Google Scholar
• Okamoto, K., and C. Prives. 1999. A role of cyclin G in the process of apoptosis. Oncogene 18: 4606–4615.
   PubMed Web of Science ®Google Scholar
• Ouchi, T., A. N. Monteiro, A. August, S. A. Aaronson, and H. Hanafusa. 1998. BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA 95: 2302–2306.
   PubMed Web of Science ®Google Scholar
• Polyak, K., Y. Xia, J. L. Zweier, K. W. Kinzler, and B. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389: 300–305.
   PubMed Web of Science ®Google Scholar
• Robertson, K. D., and P. A. Jones. 1998. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol. 18: 6457–6473.
   PubMed Web of Science ®Google Scholar
• Scully, R. 2000. Role of BRCA gene dysfunction in breast and ovarian cancer predisposition. Breast Cancer Res. 2: 324–330.
   PubMed Web of Science ®Google Scholar
• Scully, R., S. Ganesan, K. Vlasakova, J. Chen, M. Socolovsky, and D. M. Livingston. 1999. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell 4: 1093–1099.
   PubMed Web of Science ®Google Scholar
• Scully, R., and D. M. Livingston. 2000. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429–432.
   PubMed Web of Science ®Google Scholar
• Smith, P. D., S. Crossland, G. Parker, P. Osin, L. Brooks, J. Waller, E. Philp, M. R. Crompton, B. A. Gusterson, M. J. Allday, and T. Crook. 1999. Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene 18: 2451–2459.
   PubMed Web of Science ®Google Scholar
• Somasundaram, K., T. K. MacLachlan, T. F. Burns, M. Sgagias, K. H. Cowan, B. L. Weber, and W. S. El-Deiry. 1999. BRCA1 signals ARF-dependent stabilization and coactivation of p53. Oncogene 18: 6605–6614.
   PubMed Web of Science ®Google Scholar
• Somasundaram, K., H. Zhang, Y. X. Zeng, Y. Houvras, Y. Peng, G. S. Wu, J. D. Licht, B. L. Weber, and W. S. El-Deiry. 1997. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389: 187–190.
   PubMed Web of Science ®Google Scholar
• Song, S., T. K. MacLachlan, R. D. Meng, and W. S. El-Deiry. 1999. Comparative gene expression profiling in response to p53 in a human lung cancer cell line. Biochem. Biophys. Res. Commun. 264: 891–895.
   PubMedGoogle Scholar
• Sun, X. F., O. Johannsson, S. Hakansson, G. Sellberg, B. Nordenskjold, H. Olsson, and A. Borg. 1996. A novel p53 germline alteration identified in a late onset breast cancer kindred. Oncogene 13: 407–411.
   PubMedGoogle Scholar
• Takimoto, R., T. K. MacLachlan, D. T. Dicker, Y. Niitsu, T. Mori, and W. S. El-Deiry. 2002. BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation. Cancer Biol. Ther. 1: 177–186.
   PubMed Web of Science ®Google Scholar
• Tanaka, H., H. Arakawa, T. Yamaguchi, K. Shiraishi, S. Fukuda, K. Matsui, Y. Takei, and Y. Nakamura. 2000. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404: 42–49.
   PubMed Web of Science ®Google Scholar
• Tomlinson, G. E., T. T. Chen, V. A. Stastny, A. K. Virmani, M. A. Spillman, V. Tonk, J. L. Blum, N. R. Schneider, I. I. Wistuba, J. W. Shay, J. D. Minna, and A. F. Gazdar. 1998. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res. 58: 3237–3242.
   PubMedGoogle Scholar
• Wang, H., Z. C. Zeng, T. A. Bui, S. J. DiBiase, W. Qin, F. Xia, S. N. Powell, and G. Iliakis. 2001. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. Cancer Res. 61: 270–277.
   PubMed Web of Science ®Google Scholar
• Wodicka, L., H. Dong, M. Mittmann, M. H. Ho, and D. J. Lockhart. 1997. Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat. Biotechnol. 15: 1359–1367.
   PubMed Web of Science ®Google Scholar
• Wu, G. S., T. F. Burns, E. R. McDonald III, W. Jiang, R. Meng, I. D. Krantz, G. Kao, D. D. Gan, J. Y. Zhou, R. Muschel, S. R. Hamilton, N. B. Spinner, S. Markowitz, G. Wu, and W. S. El-Deiry. 1997. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17: 141–143.
   PubMed Web of Science ®Google Scholar
• Wu, G. S., and W. S. El-Deiry. 1996. Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2. Clin. Cancer Res. 2: 623–633.
   PubMedGoogle Scholar
• Xu, X., W. Qiao, S. P. Linke, L. Cao, W. M. Li, P. A. Furth, C. C. Harris, and C. X. Deng. 2001. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat. Genet. 28: 266–271.
   PubMed Web of Science ®Google Scholar
• Xu, X., Z. Weaver, S. P. Linke, C. Li, J. Gotay, X. W. Wang, C. C. Harris, T. Ried, and C. X. Deng. 1999. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3: 389–395.
   PubMed Web of Science ®Google Scholar
• Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Strong, and G. M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937–948.
   PubMed Web of Science ®Google Scholar
• Zhang, H., K. Somasundaram, Y. Peng, H. Tian, D. Bi, B. L. Weber, and W. S. El-Deiry. 1998. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16: 1713–1721.
   PubMed Web of Science ®Google Scholar
• Zheng, L., S. Li, T. G. Boyer, and W. H. Lee. 2000. Lessons learned from BRCA1 and BRCA2. Oncogene 19: 6159–6175.
   PubMedGoogle Scholar
• Zhong, Q., C. F. Chen, S. Li, Y. Chen, C. C. Wang, J. Xiao, P. L. Chen, Z. D. Sharp, and W. H. Lee. 1999. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285: 747–750.
   PubMed Web of Science ®Google Scholar
• Zhou, B. B., and S. J. Elledge. 2000. The DNA damage response: putting checkpoints in perspective. Nature 408: 433–439.
   PubMed Web of Science ®Google Scholar